Calstabin deficiency, ryanodine receptors, and sudden cardiac death

Biochemical and Biophysical Research Communications
Stephan E LehnartAndrew R Marks

Abstract

Altered cardiac ryanodine receptor (RyR2) function has an important role in heart failure and genetic forms of arrhythmias. RyR2 constitutes the major intracellular Ca2+ release channel in the cardiac sarcoplasmic reticulum (SR). The peptidyl-prolyl isomerase calstabin2 (FKBP12.6) is a component of the RyR2 macromolecular signaling complex. Calstabin2 binding to RyR2 is regulated by PKA phosphorylation of Ser2809 in RyR2. PKA phosphorylation of RyR2 decreases the binding affinity for calstabin2 and increases RyR2 open probability and sensitivity to Ca2+-dependent activation. In heart failure, a majority of studies have found that RyR2 becomes chronically PKA hyper-phosphorylated which depletes calstabin2 from the channel complex. Calstabin2 dissociation causes a diastolic SR Ca2+ leak contributing to depressed intracellular Ca2+ cycling and decreased cardiac contractility. Missense mutations linked to genetic forms of exercise-induced arrhythmias and sudden cardiac death also cause decreased calstabin2-binding affinity and leaky RyR2 channels. We review the importance of calstabin2 for RyR2 function and excitation-contraction coupling, and discuss new observations that implicate dysregulation of calstabin2 binding as a central ...Continue Reading

References

Aug 1, 1991·Journal of Molecular and Cellular Cardiology·D J BeuckelmannE Erdmann
Feb 28, 1990·Biochemical and Biophysical Research Communications·J H CollinsN Ikemoto
Nov 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·A R MarksB Nadal-Ginard
Jul 1, 1988·The Journal of Clinical Investigation·A M FeldmanC Van Dop
Nov 1, 1986·The Journal of Clinical Investigation·E MarbanW G Wier
Jul 22, 1982·The New England Journal of Medicine·M R BristowE B Stinson
Jul 1, 1983·The American Journal of Physiology·A Fabiato
Nov 3, 1995·The Journal of Biological Chemistry·M B MeyersG I Fishman
May 19, 1995·Science·M B CannellW J Lederer
Jun 1, 1994·The American Journal of Physiology·R CoronadoD M Vaughan
May 1, 1994·The Journal of Clinical Investigation·Y IshikawaC J Homcy
Jan 1, 1995·Advances in Experimental Medicine and Biology·W G Wier

❮ Previous
Next ❯

Citations

Dec 5, 2009·Naunyn-Schmiedeberg's Archives of Pharmacology·Antony J Workman
Mar 17, 2012·Pediatric Cardiology·Michela FaggioniBjörn C Knollmann
Dec 2, 2006·Nature Reviews. Drug Discovery·Stanley Nattel, Leif Carlsson
Nov 3, 2004·Nature Reviews. Genetics·Choong-Chin Liew, Victor J Dzau
Jul 14, 2010·Cardiovascular Research·Yanmin ZhangChristopher L-H Huang
Mar 23, 2011·Cardiovascular Research·Chengju TianKeshore R Bidasee
Dec 23, 2006·Clinical and Experimental Pharmacology & Physiology·A M D WatsonC N May
Aug 14, 2009·Journal of Veterinary Internal Medicine·M A OyamaC A Reynolds
Apr 9, 2011·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Susan D KranerMark M Rich
Dec 20, 2011·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Azra FatimaTomo Saric
Aug 3, 2005·The Journal of Clinical Investigation·Silvia G Priori, Carlo Napolitano
Mar 26, 2008·Circulation Journal : Official Journal of the Japanese Circulation Society·Masafumi Yano
Oct 12, 2012·Computational and Mathematical Methods in Medicine·Luyao LuXiuwei Zhu
Jun 18, 2010·Progress in Biophysics and Molecular Biology·Eun Hui Lee
May 13, 2005·Mayo Clinic Proceedings·David J TesterMichael J Ackerman
Jun 30, 2007·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Bruce B Lerman
Oct 28, 2006·International Journal of Cardiology·Lan NguyenChristopher Semsarian
Mar 25, 2008·Biophysical Journal·Jeffrey R Groff, Gregory D Smith
Oct 25, 2007·European Journal of Heart Failure·Dirk von LewinskiBurkert Pieske
Jun 21, 2007·Journal of Cardiovascular Electrophysiology·Uwais MohamedSilvia G Priori
Sep 20, 2005·Pharmacology & Therapeutics·Carlo NapolitanoSilvia G Priori
Jun 14, 2005·Pharmacology & Therapeutics·Masafumi YanoMasunori Matsuzaki
Jan 12, 2013·European Journal of Pharmacology·Debbi MacMillan
Mar 15, 2005·The Journal of Clinical Investigation·Masafumi YanoMasunori Matsuzaki
Apr 2, 2009·Organogenesis·Mario Thevis, Wilhelm Schänzer
Nov 4, 2006·Journal of Molecular and Cellular Cardiology·Christopher H GeorgeF Anthony Lai
Jun 10, 2010·European Journal of Mass Spectrometry·Mario ThevisWilhelm Schänzer
Dec 6, 2007·Circulation Journal : Official Journal of the Japanese Circulation Society·Sami F NoujaimJosé Jalife
Nov 23, 2006·Molecular and Cellular Biochemistry·Sajal ChakrabortiTapati Chakraborti
Jan 6, 2021·Pflügers Archiv : European journal of physiology·Satadru K LahiriXander H T Wehrens
Feb 16, 2021·Frontiers in Cell and Developmental Biology·Felipe Salazar-RamírezGerardo García-Rivas

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Calcium & Bioenergetics

Bioenergetic processes, including cellular respiration and photosynthesis, concern the transformation of energy by cells. Here is the latest research on the role of calcium in bioenergetics.

Arrhythmogenic Right Ventricular Dysplasia

Arrhythmogenic right ventricular dysplasia is a congenital cardiomyopathy that is characterized by infiltration of adipose and fibrous tissue into the right ventricle wall and loss of myocardial cells. Primary injuries usually are at the free wall of the right ventricular and right atria resulting in ventricular and supraventricular arrhythmias. Discover the latest research on arrhythmogenic right ventricular dysplasia here.